FDA approves Bryhali Lotion for psoriasis treatment: What to Know

If you suffer from psoriasis – a skin condition that affects more than 7.5 million people in the United States, according to the American Academy of Dermatology – You also know that progress for treatment is huge. Living with active psoriasis is no easy feat. But the good news is that there are lots of shades of new treatments that can help you handle your psoriasis symptoms, and Bryhali Lotion is the latest to be approved by the Food and Drug Administration.

Bryhali Lotion 0.01% is a new topical treatment formulated with a "super potent corticosteroid" to treat psoriasis plaques in adults. For the unknown, psoriasis is a chronic condition where your body "becomes angry with your skin, leading to red, skinny plaques that typically develop on the elbows, knees and scalp", explains Joshua Zeichner, a dermatologist and head of cosmetic and clinical research in dermatology at Mount Sinai Hospital in New York City.

These plaques, caused by a combination of factors, including genetics and environmental stressors, can pop up somewhere. "When it happens during the chest or the week between the hip and the lumbar or under the stomach, it is often red, raw and shiny," says Erum Ilyas, a dermatologist in Pennsylvania. "When it affects the nails, it may look like small pits in the nails or oil tips."

In general, antiinflammatory drugs are used to treat psoriasis. "In local cases, we can use current drugs like current cortisone creams," Zeichner says. "They work with soothing inflammation of the skin that causes red spots." However, you need to monitor the usage rate of these current ointments. "We must be careful because extended use of current cortisone creams can thin the skin and cause pimples, "he warns. But when used properly, these creams are very effective, albeit temporarily, he says.

"Bryhali Lotion uses a well-known active ingredient called halobetasol in a new proprietary lotion formulation to improve both the efficacy and safety of the drug," Zeichner said. "Unlike other topical cortisone creams, this superpower version has been safe to use for up to eight weeks straight, [and] Most others on the market should be used in just two weeks. "

The new FDA-controlled drug can help those with psoriasis manage symptoms longer and more effectively while being considered safe as a new psoriasis treatment. Bryhali Lotion's studies (two multicentre, randomized, double-blind clinical trials) have not shown any signs of skin thinning after eight weeks of use.

In addition, the formula seems legitimate. "It contains half the concentration of the active ingredient compared with the generic form, but because of the formula it has proven to be equally effective," says Zeichner. "So it's as effective, but a safer alternative to your skin."

Another big advantage is that you can use it once a day. "This is a big deal. I have patients telling me how much time they have to set aside for morning and night to apply their current subjects when they have extensive disease," says Ilyas. "Once a day it will definitely make life a little easier."

Side effects, including burning, tingling, itching and dryness may occur, so be sure to contact your dermatologist for more treatment information. Bryhali Lotion 0.01% is expected to be distributed to wholesalers in pharmaceuticals later this month.

More about psoriasis:

See now how skin care has evolved over the past 100 years: